At a news conference last week, Mr. Trump falsely stated that the Food and Drug Administration had just approved the use of an anti-malaria medication called chloroquine to treat patients infected with coronavirus. Even after the FDA chief clarified that the drug still needs to be tested for that use, Mr. Trump overstated the drug's potential upside in containing the virus. On Friday, Dr. Anthony Fauci, the nation's top infectious disease expert, called Mr. Trump's assertions about hydroxychloroquine "anecdotal" and said there is no evidence that it is effective for COVID-19 patients. But the next day, Mr. Trump was still touting the drug on social media.
Chloroquine is obtained by prescription, and Banner Health is now urging medical providers against prescribing it to people who aren't hospitalized. There are reports of people stockpiling the drug, and people with lupus, who need a version of the medication on a regular basis, say they are struggling to fill their long-standing prescriptions.
The difference between the fish tank cleaning additive that the couple took and the drug used to treat malaria is the way they are formulated.
The World Health Organization has launched a global clinical trial to study the potential effectiveness of a number of drugs to treat coronavirus, including hydroxychloroquine and chloroquine.
But Science magazine reports, "In guidance published on Friday, the US Society of Critical Care Medicine said that 'there is insufficient evidence to issue a recommendation on the use of chloroquine or hydroxychloroquine in critically ill adults with COVID-19.'" It adds that hydroxychloroquine, in particular, can have side effects, in some cases affecting the heart, which could be a serious concern for vulnerable COVID-19 patients